- Home
- IKT vs CNTN Comparison
IKT vs CNTN Comparison
Compare IKT & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.07
N/A
Current Price
$5.03
Company Overview
Basic Information| Metric | IKT | CNTN |
|---|---|---|
| Founded | 2008 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.3M | 176.6M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | IKT | CNTN |
|---|---|---|
| Price | $2.07 | $5.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 794.0K |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.51 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.33 | $4.44 |
| 52 Week High | $2.58 | $5.19 |
Technical Indicators
Market Signals| Indicator | IKT | CNTN |
|---|---|---|
| Relative Strength Index (RSI) | 67.70 | N/A |
| Support Level | $1.45 | N/A |
| Resistance Level | $2.11 | N/A |
| Average True Range (ATR) | 0.14 | 0.00 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 75.36 | 0.00 |
Price Performance
Historical Comparison IKT
CNTN
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.